Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Simple Summary Sinonasal squamous cell carcinomas are a group of diverse tumors
affecting the nasal cavity and paranasal sinuses. As a direct consequence of their rarity and …

Objective To review overall survival (OS), recurrence patterns, and prognostic factors of de
novo sinonasal squamous cell carcinoma (DN-SCC). Data Sources PubMed, Scopus, OVID …

Paranasal sinus and skull base tumors are rare aggressive head and neck cancers, and
typically present in the locally advanced stages. As a result, achieving wide surgical …

Aims Sinonasal malignancies are rare; the most common histological subtype is squamous
cell carcinoma (SCC). No randomised trial data exist to guide treatment decisions, with …

Background Sinonasal malignant tumors (SNMTs) have a high recurrence risk, which is
responsible for the poor prognosis of patients. Assessing recurrence risk in SNMT patients is …

Purpose This study aimed to compare oncologic outcomes between definitive radiation
therapy (RT) and upfront surgical resection in patients with sinonasal squamous cell …

Maxillectomy following radiation therapy has the strongest local control over maxillary sinus
cancer. However, in the advanced stage, complete resection is difficult with adequate …

Objectives This study aimed to explore the value of preoperative radiotherapy in the
comprehensive treatment of locally advanced nasal cavity and paranasal sinus squamous …

Purpose To determine oncologic outcomes for patients with T4b sinonasal squamous cell
carcinoma (SNSCC) treated with either surgery plus radiotherapy or definitive radiotherapy …